
Kelaginamane T. Hiriyanna
Examiner (ID: 837, Phone: (571)272-3307 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 398 |
| Issued Applications | 106 |
| Pending Applications | 4 |
| Abandoned Applications | 288 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7356005
[patent_doc_number] => 20040013669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Method for treating persistent pain and identifying compounds to treat persistent pain'
[patent_app_type] => new
[patent_app_number] => 10/460065
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8629
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20040013669.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460065 | Method for treating persistent pain and identifying compounds to treat persistent pain | Jun 10, 2003 | Abandoned |
Array
(
[id] => 7389899
[patent_doc_number] => 20040037819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Non-polymeric hematopoeitic cell clots for delivery of active agents'
[patent_app_type] => new
[patent_app_number] => 10/457000
[patent_app_country] => US
[patent_app_date] => 2003-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7523
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457000 | Non-polymeric hematopoeitic cell clots for delivery of active agents | Jun 5, 2003 | Abandoned |
Array
(
[id] => 7449066
[patent_doc_number] => 20040009949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/455247
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16005
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455247
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455247 | Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids | Jun 4, 2003 | Abandoned |
Array
(
[id] => 7208478
[patent_doc_number] => 20050166274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => utility
[patent_app_number] => 10/516868
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51445
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20050166274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516868 | Screening method | Jun 3, 2003 | Issued |
Array
(
[id] => 852697
[patent_doc_number] => 07378078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-27
[patent_title] => 'Compositions and methods for detecting proteolytic activity'
[patent_app_type] => utility
[patent_app_number] => 10/452184
[patent_app_country] => US
[patent_app_date] => 2003-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14000
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/378/07378078.pdf
[firstpage_image] =>[orig_patent_app_number] => 10452184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/452184 | Compositions and methods for detecting proteolytic activity | Jun 1, 2003 | Issued |
Array
(
[id] => 7263263
[patent_doc_number] => 20040241649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'RNA CONTAINING COENZYMES, BIOTIN, OR FLUOROPHORES, AND METHODS FOR THEIR PREPARATION AND USE'
[patent_app_type] => new
[patent_app_number] => 10/250029
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10469
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250029 | RNA containing coenzymes, biotin, or fluorophores, and methods for their preparation and use | May 28, 2003 | Issued |
Array
(
[id] => 7074787
[patent_doc_number] => 20050148055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Method for the biotechnological production of xylitol'
[patent_app_type] => utility
[patent_app_number] => 10/514324
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2702
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148055.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514324 | Method for the biotechnological production of xylitol | May 14, 2003 | Abandoned |
Array
(
[id] => 6824942
[patent_doc_number] => 20030235564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Compositions and devices comprising or encoding the Run x2 protein and method of use'
[patent_app_type] => new
[patent_app_number] => 10/437171
[patent_app_country] => US
[patent_app_date] => 2003-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12320
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235564.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437171 | Compositions and devices comprising or encoding the Run x2 protein and method of use | May 12, 2003 | Abandoned |
Array
(
[id] => 7461874
[patent_doc_number] => 20040197909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Parallel macromolecular delivery and biochemical/electrochemical interface to cells employing nanostructures'
[patent_app_type] => new
[patent_app_number] => 10/408294
[patent_app_country] => US
[patent_app_date] => 2003-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 17708
[patent_no_of_claims] => 245
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20040197909.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408294 | Parallel macromolecular delivery and biochemical/electrochemical interface to cells employing nanostructures | Apr 6, 2003 | Issued |
Array
(
[id] => 6769918
[patent_doc_number] => 20030215858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Enhanced gene expression system'
[patent_app_type] => new
[patent_app_number] => 10/406510
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11533
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215858.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406510 | Enhanced gene expression system | Apr 2, 2003 | Abandoned |
Array
(
[id] => 6826484
[patent_doc_number] => 20030237106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Transgenic animal containing CD200 and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/406004
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10017
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20030237106.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406004
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406004 | Transgenic animal containing CD200 and uses therefor | Apr 2, 2003 | Issued |
Array
(
[id] => 6865556
[patent_doc_number] => 20030191082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines'
[patent_app_type] => new
[patent_app_number] => 10/391216
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15817
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191082.pdf
[firstpage_image] =>[orig_patent_app_number] => 10391216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/391216 | Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines | Mar 18, 2003 | Issued |
Array
(
[id] => 7105094
[patent_doc_number] => 20050107317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Cg3842 homologous proteins involved in the regulation of energy homeostasis'
[patent_app_type] => utility
[patent_app_number] => 10/506740
[patent_app_country] => US
[patent_app_date] => 2003-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 16630
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107317.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506740 | Cg3842 homologous proteins involved in the regulation of energy homeostasis | Mar 6, 2003 | Abandoned |
Array
(
[id] => 7168287
[patent_doc_number] => 20050201996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Compositions and methods for treatment of skin disorders'
[patent_app_type] => utility
[patent_app_number] => 10/504697
[patent_app_country] => US
[patent_app_date] => 2003-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4348
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20050201996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504697
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504697 | Compositions and methods for treatment of skin disorders | Feb 16, 2003 | Abandoned |
Array
(
[id] => 5794014
[patent_doc_number] => 20060014695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Hpma-polyamine conjugates and uses therefore'
[patent_app_type] => utility
[patent_app_number] => 10/502985
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10194
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014695.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502985 | Hpma-polyamine conjugates and uses therefore | Jan 30, 2003 | Abandoned |
Array
(
[id] => 6864759
[patent_doc_number] => 20030190285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Multiple-tumor aberrant growth genes'
[patent_app_type] => new
[patent_app_number] => 10/352615
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 32903
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10352615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/352615 | Multiple-tumor aberrant growth genes | Jan 27, 2003 | Abandoned |
Array
(
[id] => 5851031
[patent_doc_number] => 20060234222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Soluble recombinant protein production'
[patent_app_type] => utility
[patent_app_number] => 10/501357
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9429
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234222.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501357 | Soluble recombinant protein production | Dec 29, 2002 | Abandoned |
Array
(
[id] => 6865555
[patent_doc_number] => 20030191081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Pharmaceutical compositions and methods of use thereof comprising polyanionic polymers and amphiphilic block copolymers to improve gene expression'
[patent_app_type] => new
[patent_app_number] => 10/329646
[patent_app_country] => US
[patent_app_date] => 2002-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4602
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191081.pdf
[firstpage_image] =>[orig_patent_app_number] => 10329646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/329646 | Pharmaceutical compositions and methods of use thereof comprising polyanionic polymers and amphiphilic block copolymers to improve gene expression | Dec 25, 2002 | Abandoned |
Array
(
[id] => 6710467
[patent_doc_number] => 20030170216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'SYN3 compositions and methods'
[patent_app_type] => new
[patent_app_number] => 10/329043
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9847
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10329043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/329043 | SYN3 compositions and methods | Dec 19, 2002 | Abandoned |
Array
(
[id] => 7679176
[patent_doc_number] => 20030167476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand'
[patent_app_type] => new
[patent_app_number] => 10/318661
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 27835
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167476.pdf
[firstpage_image] =>[orig_patent_app_number] => 10318661
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/318661 | Selective target cell activation by expression of a G protein-coupled receptor activated superiorly by synthetic ligand | Dec 11, 2002 | Abandoned |